This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

The phase 3 CONDOR trial found brolucizumab superior to panretinal laser photocoagulation for proliferative diabetic retinopathy, offering better vision outcomes and disease regression. The anti-VEGF ...

An injection of 6 mg of intravitreal brolucizumab was at least as effective as — and potentially superior to — panretinal laser photocoagulation in preserving vision in patients with proliferative ...

Cataract surgery was associated with an increased risk of worsening diabetic retinopathy in adults with type 2 diabetes. Diabetes is a risk factor for complications due to cataract surgery. Patients ...

Microaneurysms are tiny areas of swelling in the blood vessels of your eye. They can be a clue to worsening diabetic retinopathy and may indicate that you need treatment to help prevent vision loss.

Thank you to our sponsors at Johnson & Johnson, the makers of Acuvue Contact Lenses; Macuhealth; Pacific Cataract and Laser Institute; and the Oregon Optometric Physicians Association. In this ...

Investigators from Cedars-Sinai have provided new understanding of how diabetes delays wound healing in the eye, identifying for the first time two related disease-associated changes to the cornea.